|
U.S. FDA to Exempt PEPFAR Drugs From User Fees
The U.S. Food and Drug Administration (FDA) is exempting drugs that will be used for the President’s Emergency Plan for AIDS Relief (PEPFAR) from Prescription Drug User Fee Act fees to lessen the financial difficulties associated with developing the products, agency guidance says. This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives